Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.170
-0.020 (-1.68%)
Jan 5, 2026, 9:41 AM EST - Market open
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $408.8 million as of January 5, 2026. Its market cap has increased by 27.63% in one year.
Market Cap
408.80M
Enterprise Value
380.21M
1-Year Change
27.63%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $408.80M, a decrease of -92.79%. That is a compound annual growth rate of -29.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 407.20M | 4.38% |
| Dec 31, 2025 | 390.10M | 35.12% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
| May 24, 2018 | 5.67B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |